Health Care Leaders Express Doubts on Medicare's ACCESS Model Effectiveness

Health Care Leaders Skeptical About Medicare's ACCESS Model

Health care organizations are currently navigating the implications of the Medicare ACCESS model, which was launched on July 5 by the Centers for Medicare & Medicaid Services (CMS). This initiative aims to provide care management for chronic conditions through voluntary participation. However, a recent survey reveals a prevailing skepticism among leaders regarding its potential effectiveness.

Survey Insights from Value-Based Care Leaders

A survey conducted by the National Association of ACOs (NAACOS) and the health care AI firm Innovaccer found that seventy-two percent of value-based care leaders claim that ACCESS is influencing their technology strategies. Despite this, a substantial 59 percent remain uncertain about the co-management payments being a viable funding source. Only 30 percent of respondents are optimistic that these ACCESS payments will adequately support their technological investments.

The survey, which sampled 116 provider and value-based care leaders in August, depicted a reluctance to rely on ACCESS for financial backing. Effective funding is crucial for implementing new technological solutions in health care management. Many respondents expressed concerns about current operational costs and emphasized that most of their expenditures stem from their operating budgets.

Structure of the ACCESS Model

The ACCESS model aims to provide regular payments to Medicare-enrolled organizations for managing chronic conditions, including high blood pressure and diabetes. Organizations can earn payments ranging from $180 to $420 annually per patient, depending on the chronic condition track they manage. Notably, half of these payments are withheld until the end of a 12-month care period, contingent on meeting specific clinical targets.

Clinicians participating in this model can bill for co-management services up to three times per patient in a year, thus incentivizing active involvement in patient care. However, many leaders are finding the initial payment rates lower than anticipated, which may inhibit the financial backing necessary to adopt advanced care technologies.

Barriers to Technology Adoption

A significant focus of the survey was identifying barriers to adopting new technologies within the ACCESS model framework. Among respondents, forty-five percent identified funding as the primary obstacle, with fifty-one percent citing a lack of quality data and forty-five percent pointing to the need for comprehensive regulatory guidance from CMS as additional hurdles to effective implementation.

The CEO of Innovaccer, Abhinav Shashank, emphasized the importance of evidence that correlates technological investments to improved health outcomes. He stated that without strong proof of success, providers may hesitate to financially commit to new technologies despite recognizing their potential benefits.

The Future of the ACCESS Model and Patient Enrollment

Looking ahead, the ACCESS model plans to expand its chronic condition offerings in April 2027 to include heart failure, chronic obstructive pulmonary disease, and other significant health issues. This expansion aims to provide better care management options for patients with various chronic conditions. However, only twenty-one percent of the surveyed leaders are currently tracking which patients have enrolled in the ACCESS model, raising questions about patient engagement and the effectiveness of outreach efforts.

Despite the skepticism, many health care leaders are hopeful that ACCESS will ultimately yield clearer regulations, improve data-sharing capabilities, and strengthen the overall payment structure for chronic care management. As this model evolves, stakeholders recognize the pressing need for more robust partnerships among service providers to enhance patient support without fragmenting care delivery.

Conclusion

As the health care landscape adapts to the new ACCESS model, leaders remain cautious but are committed to exploring its potential to transform patient care management. The successful implementation of this model will depend significantly on collaboration among clinicians, clearer guidance from CMS, and the establishment of evidence-based practices that demonstrate tangible benefits in patient outcomes.